Detection of primary infections with pathogens

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9261510
APP PUB NO 20090042212A1
SERIAL NO

12104751

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to fusion proteins suitable as test antigens in the detection of infections with pathogens, particularly of primary infections with pathogens. Further, the invention relates to methods for detecting and differentially determining antibodies, particularly IgM antibodies resulting from an infection with a pathogenic organism. Furthermore, test reagents for carrying out these methods are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ROCHE DIAGNOSTICS OPERATIONS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Faatz, Elke Huglfing, GB 34 153
Schaarschmidt, Peter Uffing, GB 14 41
Schmitt, Urban Oberhausen, GB 36 293
Schotz, Christian Penzberg, GB 1 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 16, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00